Rheumatoid Arthritis Patients At Increased Mortality Risk If They Stop Their Statin Therapy, though taking Statins for a long period causes cardiac muscle damage
In a report from medical news it reported patients with rheumatoid arthritis (RA) who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes. There findings of a population-based study now available in Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR), RA patients should be advised of the importance of compliance to their statin therapy to reduce cardiovascular disease (CVD) mortality risk.
What are statins?
why are Statins so readily prescribed by Dr's & why has the FDA changed the side effects on their labelling?
A drug used to control cholesterol levels in patients and regularly prescibed by doctors here in the UK & in the US have had a concerning number of complaints against there effectivenss and most importantly their side effects. Data on statin usage and a link to memory loss, confusion (cognitive side effects) have been added to the labeling information.
The FDA explains that these potential cognitive consequences are reversible. The updated label also informs about reports of elevated HbA1c (glycosylated hemoglobin) and blood sugar levels. However, the Agency emphasizes that the benefits offered by statins outweigh the slightly increased risks of these adverse events. Though they have seemed to have missed that long periods of use can damage cardiac muscle in the heart, though the FDA have not thought to label this other disturbing side effect.
Written by Lewis Blackwell